Pr. Thierry Le Chevalier is Head of the Institute of Thoracic Oncology (Gustave Roussy Hospital), Paris Sud, and Associate Professor at the College of Medicine of Paris Hospitals. He is an expert in therapeutic strategies and translational research applied to lung cancer.
EFS
(Etablissement Français du Sang – French Blood Bank) transferred the PDC*vac technology to PDC*line Pharma, and provides us with privileged access to its research and GMP-compliant manufacturing infrastructures.